Trial Profile
A multi-center, open-label, unilateral interaction study of UCB 34714 on stable phenytoin monotherapy during a 45 day b.i.d. administration period in 15 adult subjects suffering from epilepsy.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2014
Price :
$35
*
At a glance
- Drugs Brivaracetam (Primary) ; Phenytoin
- Indications Epilepsy
- Focus Pharmacokinetics
- Sponsors UCB
- 16 Jul 2007 Status changed from in progress to completed.
- 20 Feb 2007 New trial record.